New Therapeutic Agents Marketed in 2022: Part 2 / Pharmacy Today AUG 2023
Four new therapeutic agents are considered in this Pharmacy Today CPE Aug 2023 review, the second in a series of articles on new therapeutic agents marketed in 2022: inclisiran sodium (Leqvio—Novartis), mavacamten (Camzyos—Bristol Myers Squibb), tezepelumab-ekko (Tezspire—AstraZeneca), and oteseconazole (Vivjoa—Mycovia).